Navigation Links
Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors

New York, NY (PRWEB) July 12, 2013

On July 12, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Shelli Kesler, a Stanford University clinical neuropsychologist, and her colleagues for using brain-training software to help lift the mental fog caused by cancer treatment.

According to a July 2nd, 2013 article entitled “Brain-training software may help lift ‘chemo fog’ cause by cancer treatment,” “Chemo fog” is a mental fuzziness induced by repeated cancer treatment. Researchers say cognitive brain exercises can improve brain function and ease the effects of the recurring chemotherapy.

Researchers went on to say that “those who used a brain-training program for 12 weeks were more cognitively flexible, more verbally fluent, and faster-thinking than survivors who didn’t train."

Shelli Kesler, the Stanford University clinical neuropsychologist who led the research, says patients who endure repeated chemotherapy treatments for cancer do show changes in brain structure and function and often have long-term cognitive effects. The new study suggests “cognitive training could be one possible avenue for helping to improve cognitive function in cancer survivors treated with chemotherapy.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, sees this brain training software as a great tool for cancer survivors. He says “This possible alternative to post-chemotherapy treatment could be a great way for survivors to feel 100 percent better, mentally. The physical effects are obvious but these mental effects can sometimes be hard to detect. Hopefully this brain-training could potentially become an effective way to help survivors on their road to recovery.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Comments on Discovery of a Cause of Resistance to Therapy in Cases of Brain Cancer
2. Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
3. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
4. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
5. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
6. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
7. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
8. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
9. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
10. Avatar therapy helps silence voices in schizophrenia
11. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: